Are results from laser/RF permanent—how long do they last?
Results from vaginal laser or radiofrequency (RF) aren’t permanent. When they help genitourinary syndrome of menopause (GSM), improvements typically build over weeks after a short series (often 2–3 sessions) and may soften again over months. Many people plan a review at 6–12 months to decide on maintenance. Benefits last longest when foundations are in place: regular vaginal moisturiser, a compatible lubricant, and—if needed—local vaginal oestrogen or DHEA. Educational only. Results vary. Not a cure.
Detailed Medical Explanation
Are results from laser/RF permanent—how long do they last? Energy-based treatments (fractional CO2/Er:YAG lasers or radiofrequency) use controlled heat to encourage collagen remodelling and blood flow in the vaginal epithelium and submucosa. For some with genitourinary syndrome of menopause (GSM), this can mean less “”sandpaper”” friction on walking or cycling, fewer micro-tears at the entrance, and easier initial penetration. However, the underlying driver—low oestrogen in peri-/post-menopause—continues, so results are not permanent. Like skin and fascia elsewhere, mucosal tissue gradually remodels again over time, which is why many people schedule a review at 6–12 months to consider maintenance.
Typical pattern in real life. After a short series (often 2–3 sessions spaced 4–8 weeks apart), improvements—when they occur—tend to accumulate over several weeks as tissue settles and remodels. Day-to-day movement may feel calmer; insertional sting can reduce; and a good lubricant seems to “”go further””. If the entrance (vestibule/posterior fourchette) was the tender hotspot, a targeted approach often matters as much as the device choice. Most clinics then check progress at 6–12 months: some people feel comfortable with foundations alone; others request a single maintenance visit; a few prefer no further sessions and instead step up local therapy for a while.
Why benefits need topping up. GSM stems from sustained low oestrogen: epithelium thins, pH rises and protective lactobacilli decline, increasing friction. Energy devices do not replace this biology; they nudge mechanical resilience. Without ongoing support (moisturiser routine ± local hormones), the environment can drift back toward dryness. Hence, we recommend pairing devices with day-to-day measures and considering local vaginal oestrogen or vaginal DHEA when symptoms are intrusive—this helps maintain a healthier pH and epithelial maturity, which prolongs comfort.
What most influences durability. 1) Foundations: a scheduled vaginal moisturiser (many prefer hyaluronic acid gels) and a compatible personal lubricant (water-based for versatility and condoms; silicone-based for long glide; oil-based feels rich but may degrade latex condoms/toys). 2) Placement: if your pain is entrance-focused, fingertip-apply local therapies right to the vestibule; internal-only use can miss the sore spot. 3) Co-drivers: manage contact irritants (perfumed washes/liners), saddle pressure (wider/cushioned seat), and tight sports kit; address pelvic floor guarding with physiotherapy/dilators if penetration pain triggered a protective clench. 4) Health events: infections (thrush/BV/UTI), new dermatological conditions (e.g., lichen sclerosus) or stress-related flares can temporarily overshadow gains—treat these specifically, then reassess.
Sequencing with other treatments. In a UK, guideline-led pathway, we start with how treatment steps are sequenced—non-hormonal foundations first; consider adding local vaginal oestrogen or DHEA if dryness and dyspareunia persist; and only then discuss devices. If you choose an energy path, schedule reviews and decide whether a 6–12 month maintenance makes sense for your goals. For clarity on what a session involves and where benefits come from, see what the treatment involves.
Setting expectations. Energy-based care is an adjunct, not a cure-all. Many feel genuinely better; some notice little change; a minority feel temporarily more sensitive before settling. Improvements, when present, are generally gradual and partial, and they last longest when you keep the basics steady and treat any coexisting issues (pelvic floor over-activity, infections, contact dermatitis). If you’ve had good early gains that fade, it’s reasonable to re-check technique, product choice and diagnosis before booking maintenance—sometimes a small tweak (e.g., switching to silicone-based lubricant for vestibular tenderness) outperforms another device session.
Clinical Context
Who tends to experience longer-lasting benefit? People who pair a structured moisturiser routine with the right lubricant and, when appropriate, local vaginal oestrogen or DHEA; who target the vestibule if that’s the soreness hotspot; and who address pelvic floor guarding with physiotherapy if penetration pain has become anticipatory. Breathable underwear and avoiding fragranced washes also reduce flare-ups.
Who might notice quicker fade? Those with ongoing irritants (tight kit, harsh cleansers, chlorine without rinsing), unaddressed infections, or entrance-focused pain where local therapy isn’t reaching the vestibule. If deep pain persists despite good surface comfort, investigate other drivers (e.g., endometriosis, pelvic floor spasm) rather than repeating device sessions.
Next steps. Keep foundations steady for 8–12 weeks post-series, then decide on a 6–12 month review. If comfort drifts, first optimise basics and placement; if still intrusive, discuss a single maintenance session versus a period of stepped-up local therapy. Aim for the lowest effective ongoing plan that keeps you comfortable.
Evidence-Based Approaches
Guideline framing. UK guidance prioritises non-hormonal measures and, when quality of life is affected, low-dose local vaginal oestrogen for GSM. See the NICE Menopause Guideline (NG23) and the NHS overview of vaginal dryness for self-care and red flags. These sources emphasise that moisture, pH and epithelial maturity respond well to local therapies, which can be maintained long term.
Comparators with stronger evidence. Systematic reviews in the Cochrane Library show that local vaginal oestrogens improve dryness, soreness, dyspareunia and pH versus placebo across creams, tablets/pessaries and rings; effects are maintained with continued use. This provides a benchmark for durability that energy devices should be compared against.
Device evidence and regulation. Peer-reviewed summaries indexed on PubMed describe potential benefits of fractional lasers/RF for GSM but note heterogeneity and limited long-term, high-quality data, hence their non–first-line position. UK device oversight principles (intended use, vigilance, and safety reporting) are outlined by the national regulator (see MHRA medical devices pages), reinforcing the need for clear consent and follow-up.
Applying the evidence: Use a stepped plan: moisturiser + compatible lubricant → add local therapy when needed → consider energy devices if guideline-led measures are insufficient or unsuitable. Expect benefits to evolve over weeks and to soften over months; plan a 6–12 month review to decide on maintenance, and keep fundamentals steady to prolong comfort. ® belongs to its owner.